Fonar Current Ratio 2006-2020 | FONR

Fonar current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Fonar Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.09B $0.02B 6.14
2019-12-31 $0.09B $0.02B 6.03
2019-09-30 $0.09B $0.01B 6.25
2019-06-30 $0.09B $0.01B 6.04
2019-03-31 $0.08B $0.01B 6.99
2018-12-31 $0.07B $0.01B 6.33
2018-09-30 $0.07B $0.01B 5.99
2018-06-30 $0.07B $0.02B 4.60
2018-03-31 $0.06B $0.01B 4.96
2017-12-31 $0.06B $0.01B 4.43
2017-09-30 $0.06B $0.01B 4.05
2017-06-30 $0.05B $0.01B 3.75
2017-03-31 $0.05B $0.01B 3.52
2016-12-31 $0.05B $0.02B 2.81
2016-09-30 $0.05B $0.02B 2.57
2016-06-30 $0.05B $0.02B 2.21
2016-03-31 $0.05B $0.02B 2.74
2015-12-31 $0.05B $0.02B 2.57
2015-09-30 $0.05B $0.02B 2.38
2015-06-30 $0.04B $0.02B 2.32
2015-03-31 $0.04B $0.02B 2.13
2014-12-31 $0.05B $0.02B 2.24
2014-09-30 $0.05B $0.02B 2.07
2014-06-30 $0.04B $0.02B 2.05
2014-03-31 $0.04B $0.02B 1.95
2013-12-31 $0.04B $0.02B 1.88
2013-09-30 $0.04B $0.02B 1.84
2013-06-30 $0.04B $0.02B 1.79
2013-03-31 $0.04B $0.02B 1.63
2012-12-31 $0.03B $0.02B 1.38
2012-09-30 $0.03B $0.02B 1.30
2012-06-30 $0.03B $0.02B 1.23
2012-03-31 $0.03B $0.02B 1.20
2011-12-31 $0.03B $0.02B 1.15
2011-09-30 $0.02B $0.02B 1.06
2011-06-30 $0.02B $0.02B 0.98
2011-03-31 $0.02B $0.02B 0.70
2010-12-31 $0.02B $0.03B 0.61
2010-09-30 $0.02B $0.03B 0.61
2010-06-30 $0.02B $0.03B 0.59
2010-03-31 $0.02B $0.03B 0.59
2009-12-31 $0.02B $0.03B 0.59
2009-09-30 $0.02B $0.03B 0.64
2009-06-30 $0.02B $0.03B 0.63
2009-03-31 $0.02B $0.03B 0.60
2008-12-31 $0.02B $0.04B 0.58
2008-09-30 $0.02B $0.04B 0.56
2008-06-30 $0.02B $0.04B 0.58
2008-03-31 $0.02B $0.04B 0.65
2007-12-31 $0.02B $0.04B 0.69
2007-09-30 $0.02B $0.03B 0.76
2007-06-30 $0.02B $0.03B 0.75
2007-03-31 $0.03B $0.03B 1.03
2006-12-31 $0.04B $0.03B 1.22
2006-09-30 $0.04B $0.02B 1.46
2006-06-30 $0.04B $0.03B 1.58
2006-03-31 $0.04B $0.02B 2.00
2005-12-31 $0.05B $0.02B 2.27
2005-09-30 $0.05B $0.02B 2.51
2005-06-30 $0.06B $0.02B 2.62
2005-03-31 $0.06B $0.02B 2.46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.136B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.573B 28.54
Medtronic (MDT) Ireland $121.803B 19.78
Stryker (SYK) United States $66.678B 21.64
Boston Scientific (BSX) United States $48.529B 22.82
Baxter (BAX) United States $43.229B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.790B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.034B 0.00
Terumo (TRUMY) Japan $28.019B 35.82
ResMed (RMD) United States $27.789B 43.86
Zimmer Biomet Holdings (ZBH) United States $24.651B 15.51
Sunny Optical Technology (SNPTF) China $19.798B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.859B 0.00
Bio-Rad Laboratories (BIO) United States $14.161B 64.46
Shandong Weigao Medical Polymer (SHWGF) China $13.702B 0.00
Insulet (PODD) United States $13.110B 1298.88
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.359B 81.40
GN STORE NORD (GNNDY) Denmark $7.527B 38.37
Perrigo (PRGO) Ireland $7.520B 13.46
Hill-Rom Holdings (HRC) United States $7.384B 20.82
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $6.112B 0.00
Haemonetics (HAE) United States $4.436B 26.64
Neogen (NEOG) United States $4.094B 69.35
GW Pharmaceuticals (GWPH) United Kingdom $3.971B 0.00
ICU Medical (ICUI) United States $3.820B 27.86
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.796B 0.00
Agios Pharmaceuticals (AGIO) United States $3.644B 0.00
Abcam (ABCZY) $3.447B 0.00
Envista Holdings (NVST) United States $3.215B 0.00
NuVasive (NUVA) United States $2.805B 22.52
TG Therapeutics (TGTX) United States $2.618B 0.00
National Vision Holdings (EYE) United States $2.314B 40.03
AtriCure (ATRC) United States $1.753B 0.00
MacroGenics (MGNX) United States $1.500B 0.00
Aurora Cannabis (ACB) Canada $1.361B 0.00
NanoString Technologies (NSTG) United States $1.319B 0.00
Aphria (APHA) Canada $1.238B 0.00
Cerus (CERS) United States $1.120B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.112B 0.00
Cardiovascular Systems (CSII) United States $1.032B 0.00
Meridian Bioscience (VIVO) United States $1.025B 38.60
Phibro Animal Health (PAHC) United States $1.015B 20.24
PetIQ (PETQ) United States $0.992B 28.64
Vapotherm (VAPO) United States $0.983B 0.00
Zynex (ZYXI) United States $0.949B 95.27
OraSure Technologies (OSUR) United States $0.833B 167.81
InMode (INMD) Israel $0.826B 17.45
Quanterix (QTRX) United States $0.772B 0.00
Omeros (OMER) United States $0.742B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.50
BioLife Solutions (BLFS) United States $0.620B 176.54
VAREX IMAGING (VREX) United States $0.586B 14.54
Lantheus Holdings (LNTH) United States $0.573B 11.54
Surmodics (SRDX) United States $0.570B 68.62
LeMaitre Vascular (LMAT) United States $0.519B 29.58
Owens & Minor (OMI) United States $0.459B 12.13
Viemed Healthcare (VMD) United States $0.408B 36.17
Cytosorbents (CTSO) United States $0.367B 0.00
HEXO (HEXO) $0.334B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.330B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.93
Organigram Holdings (OGI) Canada $0.269B 0.00
Female Health (VERU) United States $0.208B 0.00
Chimerix (CMRX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Wound Management Technologies (SMTI) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Evolus (EOLS) United States $0.108B 0.00
MTech Acquisition (KERN) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.32
Trinity Biotech (TRIB) Ireland $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.033B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00